Pathogenic factors in bronchopulmonary dysplasia

Area of Science:

• Neonatal physiology
• Biochemistry
• Pediatric medicine

Background:

• Oxygen exposure is critical for neonates but can induce oxidative stress.
• Understanding the balance of pro-oxidants and antioxidants is vital for neonatal health.
• Biomarkers of oxidative stress and antioxidant status in newborns require further investigation.

Purpose of the Study:

• To investigate serum factors related to oxygen exposure in newborns.
• To assess levels of malondialdehyde (MDA), vitamin E, ceruloplasmin, and alpha-1-antitrypsin (alpha-1-AP) in relation to gestational age and clinical factors.
• To explore the association between these factors and the development of bronchopulmonary dysplasia (BPD).

Main Methods:

• Analysis of serum samples from 56 full-term cord blood and 69 neonates of varying gestational ages.
• Measurement of serum malondialdehyde (MDA) as an indicator of lipid peroxidation.
• Assay of serum antioxidant levels, including vitamin E, ceruloplasmin (activity and protein), and alpha-1-AP (activity and protein).

Main Results:

• Serum MDA peaked at 3-5 days of life, independent of gestational age or ventilation.
• Serum vitamin E levels increased significantly after 6 days, reaching adult ranges by day 11.
• Ceruloplasmin and alpha-1-AP levels correlated with gestational age, with premature infants exhibiting lower levels and a reduced proportion of active protein.

Conclusions:

• Neonates exhibit dynamic changes in oxidative stress markers and antioxidants post-birth.
• Premature infants have diminished antioxidant capacity, particularly ceruloplasmin and alpha-1-AP.
• Lower ceruloplasmin activity in infants who developed BPD suggests a potential role in disease pathogenesis.